CN108191647B - Synthesis method of 2, 2-difluoro dicarboxylic acid dialkyl ester - Google Patents
Synthesis method of 2, 2-difluoro dicarboxylic acid dialkyl ester Download PDFInfo
- Publication number
- CN108191647B CN108191647B CN201810154079.1A CN201810154079A CN108191647B CN 108191647 B CN108191647 B CN 108191647B CN 201810154079 A CN201810154079 A CN 201810154079A CN 108191647 B CN108191647 B CN 108191647B
- Authority
- CN
- China
- Prior art keywords
- formula
- reaction
- difluorodicarboxylate
- fluorination
- esterification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000002148 esters Chemical class 0.000 title claims abstract description 8
- 238000001308 synthesis method Methods 0.000 title description 3
- 238000006243 chemical reaction Methods 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 22
- 238000003682 fluorination reaction Methods 0.000 claims abstract description 20
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000005660 chlorination reaction Methods 0.000 claims abstract description 13
- 238000005886 esterification reaction Methods 0.000 claims abstract description 13
- 230000003647 oxidation Effects 0.000 claims abstract description 13
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 13
- 230000032050 esterification Effects 0.000 claims abstract description 12
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 12
- IKGLACJFEHSFNN-UHFFFAOYSA-N hydron;triethylazanium;trifluoride Chemical compound F.F.F.CCN(CC)CC IKGLACJFEHSFNN-UHFFFAOYSA-N 0.000 claims abstract description 8
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 7
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000002253 acid Substances 0.000 claims abstract 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 6
- -1 sodium alkoxide Chemical class 0.000 claims description 5
- 239000012320 chlorinating reagent Substances 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims description 3
- VXEGSRKPIUDPQT-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(N)=CC=2)CC1 VXEGSRKPIUDPQT-UHFFFAOYSA-N 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000005049 silicon tetrachloride Substances 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 238000009776 industrial production Methods 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000003912 environmental pollution Methods 0.000 abstract description 3
- 238000007086 side reaction Methods 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- VSQNMSGIECRZCI-UHFFFAOYSA-N 3,3-difluorocyclopentene Chemical compound FC1(F)CCC=C1 VSQNMSGIECRZCI-UHFFFAOYSA-N 0.000 description 11
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical compound O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 239000007800 oxidant agent Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- YVPKMLFMDHSTKJ-UHFFFAOYSA-N diethyl 2,2-difluoropentanedioate Chemical compound CCOC(=O)CCC(F)(F)C(=O)OCC YVPKMLFMDHSTKJ-UHFFFAOYSA-N 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- APOYTRAZFJURPB-UHFFFAOYSA-N 2-methoxy-n-(2-methoxyethyl)-n-(trifluoro-$l^{4}-sulfanyl)ethanamine Chemical compound COCCN(S(F)(F)F)CCOC APOYTRAZFJURPB-UHFFFAOYSA-N 0.000 description 3
- 108010004460 Gastric Inhibitory Polypeptide Proteins 0.000 description 3
- 102100039994 Gastric inhibitory polypeptide Human genes 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012025 fluorinating agent Substances 0.000 description 3
- NALMPLUMOWIVJC-UHFFFAOYSA-N n,n,4-trimethylbenzeneamine oxide Chemical compound CC1=CC=C([N+](C)(C)[O-])C=C1 NALMPLUMOWIVJC-UHFFFAOYSA-N 0.000 description 3
- 229940032753 sodium iodate Drugs 0.000 description 3
- 235000015281 sodium iodate Nutrition 0.000 description 3
- 239000011697 sodium iodate Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- ZWPRRQZNBDYKLH-VIFPVBQESA-N Gemigliptin Chemical compound C([C@@H](N)CC(=O)N1CC2=C(C(=NC(=N2)C(F)(F)F)C(F)(F)F)CC1)N1CC(F)(F)CCC1=O ZWPRRQZNBDYKLH-VIFPVBQESA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 238000006845 Michael addition reaction Methods 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohex-2-enone Chemical compound O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- BCAZPZIWHSVWKB-UHFFFAOYSA-N diethyl 2,2-difluorohexanedioate Chemical compound CCOC(=O)CCCC(F)(F)C(=O)OCC BCAZPZIWHSVWKB-UHFFFAOYSA-N 0.000 description 2
- MBJABNQJRVFLFI-UHFFFAOYSA-N diethyl 2,2-difluorooctanedioate Chemical compound CCOC(=O)CCCCCC(C(=O)OCC)(F)F MBJABNQJRVFLFI-UHFFFAOYSA-N 0.000 description 2
- CGWYOIQNGIZMFM-UHFFFAOYSA-N dimethyl 2,2-difluoroheptanedioate Chemical compound COC(=O)CCCCC(F)(F)C(=O)OC CGWYOIQNGIZMFM-UHFFFAOYSA-N 0.000 description 2
- 229940090124 dipeptidyl peptidase 4 (dpp-4) inhibitors for blood glucose lowering Drugs 0.000 description 2
- 229960002458 gemigliptin Drugs 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000012286 potassium permanganate Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- UFXIRMVZNARBDL-UHFFFAOYSA-N trifluoro(morpholin-4-yl)-$l^{4}-sulfane Chemical compound FS(F)(F)N1CCOCC1 UFXIRMVZNARBDL-UHFFFAOYSA-N 0.000 description 2
- NSHQAIKRVDXIMX-XQRVVYSFSA-N (2z)-cyclooct-2-en-1-one Chemical compound O=C\1CCCCC\C=C/1 NSHQAIKRVDXIMX-XQRVVYSFSA-N 0.000 description 1
- 238000011925 1,2-addition Methods 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- UIZYCYUMAQWYJJ-UHFFFAOYSA-N 3,3-difluorocyclohexene Chemical compound FC1(F)CCCC=C1 UIZYCYUMAQWYJJ-UHFFFAOYSA-N 0.000 description 1
- RDEGLOWAAZUNQP-UHFFFAOYSA-N 3,3-difluorocyclooctene Chemical compound C1CC=CC(CCC1)(F)F RDEGLOWAAZUNQP-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229940124213 Dipeptidyl peptidase 4 (DPP IV) inhibitor Drugs 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- XDNFTUNCIGWHLH-UHFFFAOYSA-N F[S](F)F.C1COCCN1 Chemical compound F[S](F)F.C1COCCN1 XDNFTUNCIGWHLH-UHFFFAOYSA-N 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 1
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102100040918 Pro-glucagon Human genes 0.000 description 1
- 229910021604 Rhodium(III) chloride Inorganic materials 0.000 description 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- WZCRDVTWUYLPTR-UHFFFAOYSA-N cyclohept-2-en-1-one Chemical compound O=C1CCCCC=C1 WZCRDVTWUYLPTR-UHFFFAOYSA-N 0.000 description 1
- NGRAIMFUWGFAEM-UHFFFAOYSA-N diethyl 2-oxopentanedioate Chemical compound CCOC(=O)CCC(=O)C(=O)OCC NGRAIMFUWGFAEM-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003603 dipeptidyl peptidase IV inhibitor Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- IRSJDVYTJUCXRV-UHFFFAOYSA-N ethyl 2-bromo-2,2-difluoroacetate Chemical compound CCOC(=O)C(F)(F)Br IRSJDVYTJUCXRV-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- SONJTKJMTWTJCT-UHFFFAOYSA-K rhodium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Rh+3] SONJTKJMTWTJCT-UHFFFAOYSA-K 0.000 description 1
- YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/20—Preparation of halogenated hydrocarbons by replacement by halogens of halogen atoms by other halogen atoms
- C07C17/202—Preparation of halogenated hydrocarbons by replacement by halogens of halogen atoms by other halogen atoms two or more compounds being involved in the reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses a method for synthesizing 2, 2-difluoro dicarboxylic acid dialkyl ester, which comprises the following steps: (A) 2-cycloalken-1-one of formula I is directly fluorinated or chlorinated and then fluorinated to obtain 3, 3-difluorocycloalkene of formula II; (B) the 2, 2-difluorodicarboxylic acid dialkyl ester of the formula III is obtained from the 3, 3-difluorocycloalkene of the formula II by simultaneous oxidation and esterification or by oxidation followed by esterification. Wherein, the chlorination reagent adopted for chlorination and then fluorination is oxalyl chloride, and the fluorination reagent adopted is triethylamine trihydrofluoride; the reaction system adopted by the simultaneous oxidation and esterification is ozone gas/sodium ethoxide, and the reaction temperature is-75 to-15 ℃. The method has the advantages of novel synthetic route, less environmental pollution, lower production cost, simple and easily-operated reaction conditions, higher reaction safety and fewer side reactions, and particularly can obtain higher reaction yield by selecting proper reaction conditions, the total yield can reach more than 82 percent at most, and the method is suitable for industrial production.
Description
Technical Field
The invention belongs to the technical field of synthesis of medical intermediates, and particularly relates to a synthesis method of 2, 2-difluoro dicarboxylic acid dialkyl ester.
Background
DPP-4 inhibitor, i.e. dipeptidyl peptidase 4 inhibitor, is a kind of medicine for treating type II diabetes, and the medicine can inhibit the inactivation of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), improve the level of endogenous GLP-1 and GIP, promote the release of insulin by islet beta cells, and inhibit the secretion of glucagon by islet alpha cells, thereby improving insulin level, reducing blood sugar, and being difficult to induce hypoglycemia and increase body weight.
Gemigliptin (Gemigliptin) is a novel DPP-4 inhibitor developed by LG Life Science Ltd. Clinical studies show that the geigeritin has good effects whether being used for single treatment or being used for combined treatment with other antihyperglycemic drugs. Diethyl 2, 2-difluoroglutarate is an important intermediate for synthesizing the geagliptin (see international patent document WO2006104356A1 and Chinese document CN 101151265A).
For diethyl 2, 2-difluoroglutarate, the prior art discloses two synthetic routes:
(A) prepared by directly carrying out Michael addition reaction on ethyl acrylate and bromodifluoroacetic acid ethyl ester (see international patent document WO2013115595A1 and Chinese document CN 104159884A).
The disadvantages of this route are: (1) the Michael addition reaction is in competition with the 1, 2-addition reaction, resulting in a low yield; (2) the possibility of obtaining yields of more than 95% is most likely related to the use of the relatively expensive Tetramethylethylenediamine (TMEDA), which leads to increased production costs; (3) more copper powder is needed, the method is not environment-friendly, and the method is not suitable for industrial production.
(B) Prepared by directly carrying out fluorination reaction on diethyl 2-ketoglutarate (see U.S. patent document US 4324730A).
The disadvantages of this route are: (1) the fluorination reaction inevitably competes with 4-position fluorination, resulting in lower yields, less than 60%; (2) requires the addition of a strong fluorinating agent SF at a low temperature of-78 DEG C4Not only the reaction conditions are harsh, but also the safety is low, and the method is not suitable for industrial production.
Disclosure of Invention
The invention aims to solve the problems and provide a synthetic method of 2, 2-difluoro dicarboxylic acid dialkyl ester, which has the advantages of less environmental pollution, lower production cost, simple and easily operated reaction conditions, higher reaction safety and higher yield and is suitable for industrial production.
The technical scheme for realizing the purpose of the invention is as follows: a method for synthesizing dialkyl 2, 2-difluorodicarboxylate, comprising:
(A) reacting 2-cycloalken-1-one of formula I to obtain 3, 3-difluorocycloalkene of formula II;
(B) the dialkyl 2, 2-difluorodicarboxylate of the formula III is obtained by reacting a 3, 3-difluorocycloolefin of the formula II.
The specific synthetic route is as follows:
wherein n in the formulas I to III is an integer of 0 to 6, preferably an integer of 1 to 4, and more preferably 1; r in the formula III is C1~10Alkyl, preferably C1~4Alkyl, more preferably ethyl.
The reaction in the step A is direct fluorination or chlorination followed by fluorination; to obtain higher yields, chlorination followed by fluorination is preferred.
The fluorinating agent used for the direct fluorination is diethylaminosulfur trifluoride (hereinafter abbreviated as DAST), bis (2-methoxyethyl) aminosulfur trifluoride (hereinafter abbreviated as BAST), or morpholine sulfur trifluoride (hereinafter abbreviated as Morph-DAST); preferably DAST.
The molar ratio of the fluorinating agent used for the direct fluorination to the 2-cycloalken-1-one of the formula I is 1: 1 to 4: 1, preferably 2: 1.
The chlorinating agent used for chlorination and then fluorination is one of oxalyl chloride, thionyl chloride, silicon tetrachloride and phosphorus pentachloride, and is preferably oxalyl chloride.
The fluorination reagent adopted for chlorination and fluorination is triethylamine trihydrofluoride.
The mole ratio of the chlorination reagent, triethylamine trihydrofluoride and the 2-cycloolefine-1-ketone with the formula I adopted for chlorination and fluorination is (0.8-2.0): (0.3-1.5): 1, and the preferred ratio is 1: 0.7: 1.
The reaction of the step A is carried out in an organic solvent; the organic solvent is one or two of chlorobenzene, toluene, 1, 2-dichloroethane and 1, 4-dioxane.
The reaction temperature in the step A is 0-60 ℃; the reaction time is 3-24 h.
The reaction in the step B is simultaneous oxidation and esterification or oxidation and esterification; to obtain higher yields, simultaneous oxidation and esterification are preferred.
The reaction system adopted by the simultaneous oxidation and esterification is ozone gas/sodium alkoxide; preferably ozone gas/sodium ethoxide.
The dosage of the sodium alkoxide is 2-3 times of the molar dosage of the 3, 3-difluorocycloolefin in the formula II.
The temperature of the simultaneous oxidation and esterification reaction is-75 to-15 ℃, and is preferably-20 ℃.
The oxidizing agent adopted by the oxidation and esterification is sodium iodate or potassium permanganate.
The dosage of the oxidant is 1-2 times of the molar dosage of the 3, 3-difluorocycloolefin in the formula II.
When the adopted oxidant is sodium iodate, the reaction in the step B is 0-75 ℃, and the preferable temperature is 45 ℃.
When the adopted oxidant is sodium iodate, rhodium trichloride, ruthenium trichloride or osmium tetroxide serving as a catalyst is also required to be added; the dosage of the catalyst is 1-10% of the molar dosage of the 3, 3-difluorocycloolefin in the formula II.
When the oxidant used is potassium permanganate, the reaction in step B is-35 to-5 ℃, preferably-20 ℃.
The reaction of the step B is carried out in an organic solvent; the organic solvent is one or two of dichloromethane, diethyl ether, tetrahydrofuran, methyl tert-butyl ether and dimethyl sulfoxide (DMSO).
The invention has the following positive effects: (1) the invention has the advantages of novel synthetic route, less environmental pollution, lower production cost, simple and easy operation of reaction conditions, higher reaction safety and less side reaction. (2) The method can obtain higher reaction yield by selecting proper reaction conditions, the total yield can reach more than 82 percent at most, and the method is suitable for industrial production.
Detailed Description
(example 1)
This example is a preparation of 3, 3-difluorocyclopentene by chlorination followed by fluorination, as follows:
6.15g of 2-cyclopenten-1-one (75 mmol) was dissolved in 80mL of anhydrous chlorobenzene, and 9.52g of oxalyl chloride (75 mmol) was added dropwise thereto, and the reaction system was kept at an internal temperature of less than 20 ℃ for 20min without bubble evolution.
The reaction mixture was cooled to 0 ℃ and 16.16g of triethylamine (160 mmol) and 8.37g of triethylamine trihydrofluoride (52 mmol) were added in this order, and the mixture was stirred at 40 ℃ for 3 hours.
After the reaction is finished, cooling the reaction system to 0 ℃, adding 50mL of water, stirring, standing, separating, washing the organic layer with deionized water, separating the water phase, drying the organic layer with anhydrous sodium sulfate, filtering, distilling at normal pressure, and collecting the fraction with the boiling point lower than 70 ℃ to obtain 6.86g of colorless transparent liquid 3, 3-difluorocyclopentene, wherein the yield is 87.9%.
(examples 2 to 5)
All the examples are chlorinated and then fluorinated to prepare the 3, 3-difluorocyclopentene, and the specific method is basically the same as that of example 1 except for the differences shown in Table 1.
TABLE 1
| Example 1 | Example 2 | Example 3 | Example 4 | Example 5 | |
| 2-cyclopenten-1-ones | 6.15g/75mmol | 6.15g/75mmol | 6.15g/75mmol | 6.15g/75mmol | 6.15g/75mmol |
| Chlorination reagent | 9.52g oxalyl chloride/75 mmol | 8.93g thionyl chloride/75 mmol | 15.64g phosphorus pentachloride/75 mmol | 19.05g oxalyl chloride/150 mmol | 7.62g oxalyl chloride/60 mmol |
| Triethylamine trihydrofluoride salt | 8.37g/52mmol | 8.37g/52mmol | 8.37g/52mmol | 18.11g/112.5mmol | 7.25g/45mmol |
| 3, 3-difluorocyclopentene | 6.86g | 6.65g | 6.62g | 6.94g | 6.40g |
| Yield of | 87.9% | 85.3% | 84.9% | 89.0% | 82.1% |
(example 6)
This example is a direct fluorination to prepare 3, 3-difluorocyclopentene as follows:
6.15g of 2-cyclopenten-1-one (75 mmol) were dissolved in 150mL of 1, 2-dichloroethane, 24.15g of DAST (150 mmol) were slowly added dropwise thereto, and the reaction was stirred at room temperature for 6 hours while maintaining the internal temperature at less than 20 ℃.
After the reaction is finished, washing, standing, separating liquid, washing the organic layer with deionized water, separating water phase, drying the organic layer with anhydrous sodium sulfate, filtering, distilling at normal pressure, collecting fractions with boiling points lower than 70 ℃ to obtain 5.93g of colorless transparent liquid 3, 3-difluorocyclopentene, wherein the yield is 76.0%.
(examples 7 to 10)
All the examples are directly fluorinated to prepare 3, 3-difluorocyclopentene, and the specific method is basically the same as that of example 6 except that the differences are shown in Table 2.
TABLE 2
| Example 6 | Example 7 | Example 8 | Example 9 | Example 10 | |
| 2-cyclopenten-1-ones | 6.15g/75mmol | 6.15g/75mmol | 6.15g/75mmol | 6.15g/75mmol | 6.15g/75mmol |
| DAST | 24.15g/150mmol | / | / | 12.08g/75mmol | 36.23g/225mmol |
| BAST | / | 33.15g/150mmol | / | / | / |
| Morph-DAST | / | / | 26.25g/150mmol | / | / |
| 3, 3-difluorocyclopentene | 5.93g | 5.90g | 5.92g | 5.86g | 5.95g |
| Yield of | 76.0% | 75.6% | 75.9% | 75.1% | 76.3% |
(example 11)
This example is a process for preparing diethyl 2, 2-difluoroglutarate by simultaneous oxidation and esterification, as follows:
the 3, 3-difluorocyclopentene (66 mmol) obtained in example 1 was dissolved in 132mL of dichloromethane, 55mL of a 2.5mol/L aqueous solution of sodium ethoxide was added, and then cooled to-20 ℃ and ozone gas was slowly introduced, and the reaction system turned pale blue after 50 min.
After the reaction, stopping introducing ozone gas, adding methyl tert-butyl ether and water into the reaction system for dilution, stirring, standing for liquid separation, extracting a water layer by using methyl tert-butyl ether, combining organic phases, drying an organic layer by using anhydrous sodium sulfate, filtering, concentrating a filtrate to obtain a bright yellow oily substance, carrying out reduced pressure distillation, and collecting a main fraction to obtain 13.6g of light yellow transparent liquid 2, 2-diethyl difluoroglutarate, wherein the yield is 92.0%.
The overall yield of the two steps was 81.0%.
(examples 12 to 15)
All the examples are to prepare 2, 2-difluoro-diethyl glutarate by simultaneous oxidation and esterification, and the specific method is basically the same as that of example 11 except that the difference is shown in Table 3.
TABLE 3
| Example 11 | Example 12 | Example 13 | Example 14 | Example 15 | |
| 3, 3-difluorocyclopentene | 66mmol | 66mmol | 66mmol | 66mmol | 66mmol |
| 2.5mol/L sodium ethoxide aqueous solution | 55mL | 60mL | 55mL | 55mL | 60mL |
| Reaction temperature | -20℃ | -20℃ | -30℃ | -20℃ | -30℃ |
| Organic solvent | 132mL of methylene chloride | 132mL of methylene chloride | 132mL of methylene chloride | 132mL of diethyl ether | 132mL of tetrahydrofuran |
| 2, 2-Difluoropentanedioic acid diethyl ester | 13.6g | 13.7g | 13.5g | 13.4g | 13.1g |
| Yield of | 92.0% | 92.7% | 91.3% | 90.6% | 88.6% |
(examples 16 to 18)
Diethyl 2, 2-difluoroadipate, dimethyl 2, 2-difluoropimelate and diethyl 2, 2-difluorosuberate were synthesized by the methods of example 1 and example 11, and are specifically shown in table 4.
TABLE 4
| Examples 1 and 11 | Example 16 | Example 17 | Example 18 | |
| 2-cycloalken-1-ones | 6.15g of 2-cyclopenten-1-one- 75mmol | 7.2g of 2-cyclohexen-1-one/75 mmol | 8.25g of 2-cyclohepten-1-one/75 mmol | 9.3g of 2-cycloocten-1-one/75 mmol |
| 3, 3-difluorocycloalkene | 6.86g of 3, 3-difluorocyclopentene | 7.72g of 3, 3-difluorocyclohexene | 8.64g of 3, 3-difluorocycloheptene | 9.45g of 3, 3-difluorocyclooctene |
| Dialkyl 2, 2-difluorodicarboxylate Esters | 13.6g of diethyl 2, 2-difluoroglutarate Esters | 13.9g of diethyl 2, 2-difluoroadipate | 12.7g of dimethyl 2, 2-difluoropimelate | 14.4g of diethyl 2, 2-difluorooctanedioate |
| Two-step overall yield | 81.0% | 77.9% | 75.6% | 72.2% |
Claims (9)
1. A method for synthesizing dialkyl 2, 2-difluorodicarboxylate is characterized by comprising the following steps:
(A) reacting 2-cycloalken-1-one of formula I to obtain 3, 3-difluorocycloalkene of formula II;
(B) reacting 3, 3-difluorocycloalkene of formula II to obtain 2, 2-difluorodicarboxylic acid dialkyl ester of formula III;
the specific synthetic route is as follows:
wherein n in the formulas I to III is an integer of 0 to 6; r in the formula III is C1~10An alkyl group;
the reaction in the step A is direct fluorination or chlorination followed by fluorination; the reaction in the step B is simultaneous oxidation and esterification.
2. The method of synthesizing dialkyl 2, 2-difluorodicarboxylate of claim 1, wherein: n in formulas I to III is an integer of 1 to 4; r in the formula III is C1~4An alkyl group.
3. The method of synthesizing dialkyl 2, 2-difluorodicarboxylate of claim 2, wherein: n in formulas I to III is 1; r in the formula III is ethyl.
4. The method of synthesizing dialkyl 2, 2-difluorodicarboxylate of claim 1, wherein: the reaction in the step A is chlorination and then fluorination; the adopted chlorinating agent is one of oxalyl chloride, thionyl chloride, silicon tetrachloride and phosphorus pentachloride; the fluorination reagent used was triethylamine trihydrofluoride salt.
5. The method of synthesizing dialkyl 2, 2-difluorodicarboxylate of claim 4, wherein: the mol ratio of the chlorination reagent to the triethylamine trihydrofluoride salt to the 2-cycloen-1-one of the formula I is (0.8-2.0): (0.3-1.5): 1.
6. The method of synthesizing dialkyl 2, 2-difluorodicarboxylate of claim 5, wherein: the molar ratio of the chlorinating agent, triethylamine trihydrofluoride and 2-cycloalken-1-one of the formula I is 1: 0.7: 1.
7. The method of synthesizing dialkyl 2, 2-difluorodicarboxylate of claim 4, wherein: the chlorinating agent used was oxalyl chloride.
8. The method of synthesizing dialkyl 2, 2-difluorodicarboxylate of claim 1, wherein: the reaction in the step B is simultaneous oxidation and esterification; the adopted reaction system is ozone gas/sodium alcoholate; the using amount of the sodium alkoxide is 2-3 times of the molar using amount of the 3, 3-difluorocycloolefin shown in the formula II; the reaction temperature is-75 to-15 ℃.
9. The method of synthesizing dialkyl 2, 2-difluorodicarboxylate of claim 8, wherein: the adopted reaction system is ozone gas/sodium ethoxide; the reaction temperature was-20 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810154079.1A CN108191647B (en) | 2018-02-22 | 2018-02-22 | Synthesis method of 2, 2-difluoro dicarboxylic acid dialkyl ester |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810154079.1A CN108191647B (en) | 2018-02-22 | 2018-02-22 | Synthesis method of 2, 2-difluoro dicarboxylic acid dialkyl ester |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108191647A CN108191647A (en) | 2018-06-22 |
| CN108191647B true CN108191647B (en) | 2020-09-29 |
Family
ID=62594058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810154079.1A Active CN108191647B (en) | 2018-02-22 | 2018-02-22 | Synthesis method of 2, 2-difluoro dicarboxylic acid dialkyl ester |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108191647B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113045380B (en) * | 2019-12-26 | 2023-03-14 | 中蓝晨光化工研究设计院有限公司 | Method for preparing fluorine-containing dihydric alcohol from fluorine-containing cycloolefin |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010134580A1 (en) * | 2009-05-21 | 2010-11-25 | 静岡県公立大学法人 | Method for producing aromatic fluorine compound and novel compound |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4324730A (en) * | 1979-10-10 | 1982-04-13 | The University Of Chicago | Certain fluorine substituted PGI2 compounds |
| JP4517458B2 (en) * | 2000-06-14 | 2010-08-04 | Dic株式会社 | Process for producing 6-bromo-1,2-difluoronaphthalene |
| US6455744B1 (en) * | 2001-01-23 | 2002-09-24 | Air Products And Chemicals, Inc. | Synthesis of vicinal difluoro aromatics and intermediates thereof |
| TWI357902B (en) * | 2005-04-01 | 2012-02-11 | Lg Life Science Ltd | Dipeptidyl peptidase-iv inhibiting compounds, meth |
| WO2013115595A1 (en) * | 2012-02-03 | 2013-08-08 | 주식회사 엘지생명과학 | Method for preparing compound by novel michael addition reaction using water or various acids as additive |
| US9899600B2 (en) * | 2012-11-26 | 2018-02-20 | Heesung Material Ltd. | Multicyclic aromatic compound and organic light emitting device using the same |
| JP2016505216A (en) * | 2013-01-03 | 2016-02-18 | メルク パテント ゲーエムベーハー | Ultraviolet emitters containing multiple bonds |
| CA2921880A1 (en) * | 2013-08-22 | 2015-02-26 | F. Hoffmann-La Roche Ag | Alkynyl alcohols and methods of use |
-
2018
- 2018-02-22 CN CN201810154079.1A patent/CN108191647B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010134580A1 (en) * | 2009-05-21 | 2010-11-25 | 静岡県公立大学法人 | Method for producing aromatic fluorine compound and novel compound |
Non-Patent Citations (1)
| Title |
|---|
| Stereospecific mono- and difluorination of the C7-bridge of norbornenes;David E. Rajsfus等;《Journal of Fluorine Chemistry》;20111231;第132卷;第339-347页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108191647A (en) | 2018-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2384368T3 (en) | Process for preparing derivatives of 1- (2-halobiphenyl-4-yl) -cyclopropanecarboxylic acid | |
| Zhu et al. | Copper (0)-mediated fluoroalkylation of iodobenzene with 2-bromo-1, 1, 2, 2-tetrafluoroethyl compounds: investigation on the influence of R substituent on the reactivity of RCF2Cu species | |
| CN108191647B (en) | Synthesis method of 2, 2-difluoro dicarboxylic acid dialkyl ester | |
| CN102690194B (en) | Preparation method of 3-cyclopropylmethoxy-4-difluoromethoxy-benzoic acid | |
| CN104159884B (en) | Process for preparing compounds by novel Michael addition reaction using water or various acids as additives | |
| CN1191856A (en) | Process for preparing cyclopropylacetylene derivatives | |
| CN103467445B (en) | Preparation method of alogliptin benzoate | |
| CN115286491B (en) | Preparation method of 2- [2- (6-bromohexyloxy) ethoxymethyl ] -1, 3-dichlorobenzene | |
| ES2366745T3 (en) | METHOD FOR PRODUCING BENCENDIMETHANOL REPLACED WITH HALOGEN. | |
| JP2002037759A (en) | Method for producing acrylic acid ester or methacrylic acid ester | |
| EP2651868A2 (en) | Process for the preparation of atovaquone | |
| JP4269902B2 (en) | Method for producing aromatic unsaturated compound | |
| CS208795B2 (en) | Method of making the 3-phenoxybenzaldehydes | |
| US20010020110A1 (en) | Production methods of alpha, alpha, alpha-trifluoromethylphenyl-substituted benzoic acid and intermediate therefor | |
| CN110452199B (en) | Preparation method of feloxicib | |
| JP6124015B2 (en) | Method for producing pentafluorosulfanylbenzoic acid | |
| KR20120128097A (en) | Precursor of f-labeled pet radiopharmaceuticlas and preparation method thereof | |
| CZ2001416A3 (en) | Process for preparing 3,5-bis-(trifluoromethyl)-benzoyl chlorides and 3,5-bis-(trihalomethyl)-benzoyl halides and 3,5-dimethylbenzoyl halides | |
| JPH0819007B2 (en) | Method for halogenating aromatic compounds | |
| JP3259893B2 (en) | Method for producing 3,3-dichloro-1,1,1-trifluoropropan-2-one | |
| JP2897833B2 (en) | Method for producing 2-chloro-4-fluorophenol | |
| JP3261474B2 (en) | Method for producing 2-chloro-4,5-difluorobenzoic acid | |
| JPH04308538A (en) | Halogenation | |
| CN100404479C (en) | Process for the preparation of aromatic unsaturated compounds | |
| JPS6059221B2 (en) | Method for producing alkylcyclopropylketone derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |